314 related articles for article (PubMed ID: 22007611)
1. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
[TBL] [Abstract][Full Text] [Related]
3. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
4. Bradycardia related to ribavirin in four pediatric patients with Crimean-Congo hemorrhagic fever.
Tezer H; Ozkaya Parlakay A; Gülhan B; Cetin I
Vector Borne Zoonotic Dis; 2014 Jun; 14(6):464-5. PubMed ID: 24745325
[TBL] [Abstract][Full Text] [Related]
5. Crimean Congo hemorrhagic fever: requires vigilance and not panic.
Bajpai S; Nadkar MY
J Assoc Physicians India; 2011 Mar; 59():164-7. PubMed ID: 21751625
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
Mardani M; Jahromi MK; Naieni KH; Zeinali M
Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
[TBL] [Abstract][Full Text] [Related]
9. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy.
Ozkurt Z; Kiki I; Erol S; Erdem F; Yilmaz N; Parlak M; Gundogdu M; Tasyaran MA
J Infect; 2006 Mar; 52(3):207-15. PubMed ID: 15953646
[TBL] [Abstract][Full Text] [Related]
10. Crimean-Congo hemorrhagic fever.
Vorou R; Pierroutsakos IN; Maltezou HC
Curr Opin Infect Dis; 2007 Oct; 20(5):495-500. PubMed ID: 17762783
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study.
Izadi S; Salehi M
Jpn J Infect Dis; 2009 Jan; 62(1):11-5. PubMed ID: 19168952
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.
Hekimoğlu HC; Demirci NA
Afr Health Sci; 2014 Dec; 14(4):873-81. PubMed ID: 25834496
[TBL] [Abstract][Full Text] [Related]
13. EPIDEMIOLOGY, CLINICAL AND LABORATORY FEATURES OF CRIMEAN-CONGO HEMORRHAGIC FEVER IN GEORGIA.
Vashakidze E; Mikadze I
Georgian Med News; 2015 Oct; (247):54-8. PubMed ID: 26483375
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
[TBL] [Abstract][Full Text] [Related]
16. Current treatment of Crimean-Congo hemorrhagic fever in children.
Mardani M; Rahnavardi M; Sharifi-Mood B
Expert Rev Anti Infect Ther; 2010 Aug; 8(8):911-8. PubMed ID: 20695747
[TBL] [Abstract][Full Text] [Related]
17. [Crimean-Congo hemorrhagic fever: basics for general practitioners].
Flusin O; Iseni F; Rodrigues R; Paranhos-Baccalà G; Crance JM; Marianneau P; Bouloy M; Peyrefitte CN
Med Trop (Mars); 2010 Dec; 70(5-6):429-38. PubMed ID: 21520641
[TBL] [Abstract][Full Text] [Related]
18. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin.
Kurnaz F; Metan G; Coskun R; Kaynar L; Eser B; Doganay M
Trop Doct; 2011 Jul; 41(3):181-2. PubMed ID: 21565949
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of Efficacy of Ribavirin on Laboratory Test and Severity Score in Crimean-Congo Hemorrhagic Fever in Children].
Karaaslan E; Çetin Ş
Mikrobiyol Bul; 2021 Apr; 55(2):180-193. PubMed ID: 33882650
[TBL] [Abstract][Full Text] [Related]
20. Crimean-Congo hemorrhagic fever with hepatic impairment and vaginal hemorrhage: a case report.
Muco E; Como N; Bino S; Harxhi A; Pipero P; Kota M; Mehmeti J; Kushi A; Kraja D
J Med Case Rep; 2018 May; 12(1):118. PubMed ID: 29724249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]